Alexion Pharmaceuticals (ALXN -1.2%) says its Board of Directors has authorized a $400M stock...

|About: Alexion Pharmaceuticals, Inc. (ALXN)|By:, SA News Editor

Alexion Pharmaceuticals (ALXN -1.2%) says its Board of Directors has authorized a $400M stock buyback. The Board's authorization is open-ended and doesn't establish a timeframe for the purchases, and the company expects to fund all repurchases from cash on hand and future cash flows from operations.